1. Lasseter KC, Shamblen EC, Lettieri J, Kml G, Taylor RJ, Fein SH (1987) Dose-proportional pharmacokinetics of nisoldipine in healthy volunteers. Clin Pharmacol Ther 41: 234
2. Edgar B, Bailey D, Bergstrand R, Johnsson G, Regardh CG (1992) Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipineand its potential clinical relevance. Eur J Pharmacol 42: 313–317
3. Bolaert J, Valcke Y, Dammekens H, Devries G, Schurgers M, Daneels R, Bogaert MG (1988) Pharmacokinetics of nisoldipine in renal dysfunction. Eur J Clin Pharmacol 34: 207–209
4. Breimer DD, Lodewijks MTM, Van Brummelen P, Van Harten J, Wilson JPH (1986) Pharmacokinetics and haemodynanic effects of nisoldipine in patients with liver cirrhosis. BrJ Pharmacol 89 (Suppl): 482
5. Joeres R, Ahr G, Hofstetter G, Klinker H, Richter E (1987) Steady state pharmacokinetics of nisoldipine in patients with liver disease. In: Hugenholtz PG, Meyer J, eds. Nisoldipine 1987. Berlin-Heidelberg: Springer-Verlag 80–84